{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:38:38Z","timestamp":1788359918529,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Previous studies suggest that oxidative stress plays an important role in the development of breast cancer. There is a significant inverse relationship between HDL and the risk and mortality of breast cancer. However, it is well known that under conditions of oxidative stress, such as breast cancer, HDL can be oxidatively modifiedand these modifications may have an effect on the functions of HDL. The purpose of this study is to determine the different effects of normal and oxidized (caused by hypochlorite-induced oxidative stress) HDL on breast cancer cell metastasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Human breast cancer cell lines were treated with normal and hypochlorite-oxidized HDL, and then cell metastasis potency <jats:italic>in vivo<\/jats:italic> and the abilities of migration, invasion, adhesion to HUVEC and ECM <jats:italic>in vitro<\/jats:italic> were examined. Integrin expression and PKC activity were evaluated, and PKC inhibitor and PKC siRNA was applied.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We found hypochlorite-oxidized HDL dramatically promotes breast cancer cell pulmonary metastasis (133.4% increase at <jats:italic>P<\/jats:italic> &lt; 0.0 l for MDA-MB-231 by mammary fat pad injection; 164.3% increase at <jats:italic>P<\/jats:italic> &lt; 0.01 for MCF7 by tail vein injection) and hepatic metastasis (420% increase at <jats:italic>P<\/jats:italic> &lt; 0.0 l for MDA-MB-231 by mammary fat pad injection; 1840% fold increase at <jats:italic>P<\/jats:italic> &lt; 0.001 for MCF7 by tail vein injection) in nude mice, and stimulates higher cell invasion (85.1% increase at <jats:italic>P<\/jats:italic> &lt; 0.00 l for MDA-MB-231; 88.8% increase at <jats:italic>P<\/jats:italic> &lt; 0.00 l for MCF7;), TC-HUVEC adhesion (43.4% increase at <jats:italic>P<\/jats:italic> &lt; 0.00 l for MDA-MB-231; 35.2% increase at <jats:italic>P<\/jats:italic> &lt; 0.00 l for MCF7), and TC-ECM attachment (41.0% increase at <jats:italic>P<\/jats:italic> &lt; 0.00 l for MDA-MB-231; 26.7% increase at <jats:italic>P<\/jats:italic> &lt; 0.05 for MCF7) <jats:italic>in vitro<\/jats:italic> compared with normal HDL. The data also shows that the PKC pathway is involved in the abnormal actions of hypochlorite-oxidized HDL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our study demonstrated that HDL under hypochlorite-induced oxidative stress stimulates breast cancer cell migration, invasion, adhesion to HUVEC and ECM, thereby promoting metastasis of breast cancer. These results suggest that HDL-based treatments should be considered for treatment of breast cancer patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1479-5876-10-65","type":"journal-article","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T18:14:04Z","timestamp":1333131244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis"],"prefix":"10.1186","volume":"10","author":[{"given":"Bing","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoqi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenguang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinge","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangzhu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-bing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Willard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,30]]},"reference":[{"key":"1036_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P: Global Cancer Statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322\/canjclin.55.2.74.","journal-title":"CA Cancer J Clin"},{"key":"1036_CR2","volume-title":"The World Health Report","author":"World Health Organization","year":"1997","unstructured":"World Health Organization: The World Health Report. 1997, Geneva: WHO"},{"key":"1036_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/bcr1628","volume":"9","author":"MG Dom\u00ednguez","year":"2007","unstructured":"Dom\u00ednguez MG, Jiang X, Castelao JE: Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis. Breast Cancer Res. 2007, 9: 201-211.","journal-title":"Breast Cancer Res"},{"key":"1036_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1474-8673.2002.00253.x","volume":"22","author":"C Sand","year":"2002","unstructured":"Sand C, Peters SLM, Mathy M-J: The effects of hypochlorite-induced oxidative stress on presynaptic M2-receptors at sympathetic nerve endings in the rat tail artery. Auton Autacoid Pharmacol. 2002, 22: 127-132. 10.1046\/j.1474-8673.2002.00253.x.","journal-title":"Auton Autacoid Pharmacol"},{"issue":"S1","key":"1036_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000086626","volume":"69","author":"C Wittekind","year":"2005","unstructured":"Wittekind C, Neid M: Cancer invasion and metastasis. Oncology. 2005, 69 (S1): 14-16.","journal-title":"Oncology"},{"key":"1036_CR6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massagu\u00e9 J: Cancer metastasis: building a framework. Cell. 2006, 127: 679-695. 10.1016\/j.cell.2006.11.001.","journal-title":"Cell"},{"key":"1036_CR7","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F","volume":"80","author":"EC Woodhouse","year":"1997","unstructured":"Woodhouse EC, Chuaqui RF, Liotta LA: General mechanisms of metastasis. Cancer. 1997, 80: 1529-1537. 10.1002\/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F.","journal-title":"Cancer"},{"key":"1036_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10555-010-9211-x","volume":"29","author":"R Rathinam","year":"2010","unstructured":"Rathinam R, Alahari SK: Important role of integrins in the cancer biology. Cancer Metastasis Rev. 2010, 29: 223-237. 10.1007\/s10555-010-9211-x.","journal-title":"Cancer Metastasis Rev"},{"key":"1036_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/ajcp\/107.1.56","volume":"107","author":"MB Cohen","year":"1997","unstructured":"Cohen MB, Griebling TL, Ahaghotu CA, Rokhlin OW, Ross JS: Cellular adhesion molecules in urologic malignancies. Am J Clin Pathol. 1997, 107: 56-63.","journal-title":"Am J Clin Pathol"},{"key":"1036_CR10","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1038\/sj.onc.1209361","volume":"25","author":"M Tan","year":"2006","unstructured":"Tan M, Li P, Sun M, Yin G, Yu D: Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors. Oncogene. 2006, 25: 3286-3295. 10.1038\/sj.onc.1209361.","journal-title":"Oncogene"},{"key":"1036_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1677\/erc.0.0100389","volume":"10","author":"HJ Mackay","year":"2003","unstructured":"Mackay HJ, Twelves CJ: Protein kinase C: a target for anticancer drugs. Endocr Relat Cancer. 2003, 10: 389-396. 10.1677\/erc.0.0100389.","journal-title":"Endocr Relat Cancer"},{"key":"1036_CR12","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1093\/emboj\/18.14.3909","volume":"18","author":"T Ng","year":"1999","unstructured":"Ng T, Shima D, Squire A, Bastiaens PI, Gschmeissner S, Humphries MJ, Parker PJ: PKC alpha regulates beta1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J. 1999, 18: 3909-3923. 10.1093\/emboj\/18.14.3909.","journal-title":"EMBO J"},{"key":"1036_CR13","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.1128\/MCB.22.16.5897-5911.2002","volume":"22","author":"M Parsons","year":"2002","unstructured":"Parsons M, Keppler MD, Kline A, Messent A, Humphries MJ, Gilchrist R, Hart IR, Quittau-Prevostel C, Hughes WE, Parker PJ, Ng T: Site-directed perturbation of protein kinase C- integrin interaction blocks carcinoma cell chemotaxis. Mol Cell Biol. 2002, 22: 5897-5911. 10.1128\/MCB.22.16.5897-5911.2002.","journal-title":"Mol Cell Biol"},{"key":"1036_CR14","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0955-0674(97)80127-5","volume":"9","author":"W Kolanus","year":"1997","unstructured":"Kolanus W, Seed B: Integrins and inside-out signal transduction: converging signals from PKC and PIP3. Curr Opin Cell Biol. 1997, 9: 725-731. 10.1016\/S0955-0674(97)80127-5.","journal-title":"Curr Opin Cell Biol"},{"key":"1036_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.med.54.101601.152409","volume":"54","author":"G Assmann","year":"2003","unstructured":"Assmann G, Nofer JR: Atheroprotective effects of high-density lipoproteins. Annu Rev Med. 2003, 54: 321-341. 10.1146\/annurev.med.54.101601.152409.","journal-title":"Annu Rev Med"},{"key":"1036_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/pr.58.3.1","volume":"58","author":"A Kontush","year":"2006","unstructured":"Kontush A, Chapman MJ: Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev. 2006, 58: 342-374. 10.1124\/pr.58.3.1.","journal-title":"Pharmacol Rev"},{"key":"1036_CR17","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/j.jacc.2009.12.069","volume":"55","author":"H Jafri","year":"2010","unstructured":"Jafri H, Alsheikh-Ali AA, Karas RH: Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J Am Coll Cardiol. 2010, 55: 2846-2854. 10.1016\/j.jacc.2009.12.069.","journal-title":"J Am Coll Cardiol"},{"key":"1036_CR18","first-page":"483","volume":"7","author":"PG Moorman","year":"1998","unstructured":"Moorman PG, Hulka BS, Hiatt RA, Krieger N, Newman B, Vogelman JH, Orentreich N: Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev. 1998, 7: 483-488.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1036_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.annepidem.2008.06.006","volume":"18","author":"AM Kucharska-Newton","year":"2008","unstructured":"Kucharska-Newton AM, Rosamond WD, Mink PJ, Alberg AJ, Shahar E, Folsom AR: HDL-cholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol. 2008, 18: 671-677. 10.1016\/j.annepidem.2008.06.006.","journal-title":"Ann Epidemiol"},{"key":"1036_CR20","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/jnci\/djh216","volume":"96","author":"AS Furberg","year":"2004","unstructured":"Furberg AS, Veier\u00f8d MB, Wilsgaard T, Bernstein L, Thune I: Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst. 2004, 96: 1152-1160. 10.1093\/jnci\/djh216.","journal-title":"J Natl Cancer Inst"},{"key":"1036_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1172\/JCI200421109","volume":"114","author":"L Zheng","year":"2004","unstructured":"Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, Schmitt D, Fu X, Thomson L, Fox PL: Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest. 2004, 114: 529-541.","journal-title":"J Clin Invest"},{"key":"1036_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/MED.0b013e32832922fc","volume":"16","author":"H Feng","year":"2009","unstructured":"Feng H, Li XA: Dysfunctional high-density lipoprotein. Curr Opin Endocrinol Diabetes Obes. 2009, 16: 156-162. 10.1097\/MED.0b013e32832922fc.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1036_CR23","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1158\/1078-0432.CCR-11-0817","volume":"18","author":"B Pan","year":"2012","unstructured":"Pan B, Ren H, He Y, Lv X, Ma Y, Li J, Huang L, Yu B, Kong J, Niu C: HDL of patients with type 2 diabetes mellitus elevates the capability of promoting breast cancer metastasis. Clin Cancer Res. 2012, 18: 1246-1256. 10.1158\/1078-0432.CCR-11-0817.","journal-title":"Clin Cancer Res"},{"key":"1036_CR24","volume-title":"Int J Cancer","author":"B Pan","year":"2011","unstructured":"Pan B, Ren H, Ma Y, Liu D, Yu B, Ji L, Pan L, Li J, Yang L, Lv X: HDL of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells. Int J Cancer. 2011, doi: 10.1002\/ijc.26341,"},{"key":"1036_CR25","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI107470","volume":"52","author":"EA Jaffe","year":"1973","unstructured":"Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973, 52: 2745-2756. 10.1172\/JCI107470.","journal-title":"J Clin Invest"},{"key":"1036_CR26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0022-2275(20)39807-2","volume":"21","author":"BH Chung","year":"1980","unstructured":"Chung BH, Wilkinson T, Geer JC, Segrest JP: Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res. 1980, 21: 284-291.","journal-title":"J Lipid Res"},{"key":"1036_CR27","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1021\/bi7023783","volume":"47","author":"S Jayaraman","year":"2008","unstructured":"Jayaraman S, Gantz DL, Gursky O: Effects of protein oxidation on the structure and stability of model discoidal high-density lipoproteins. Biochemistry. 2008, 47: 3875-3882. 10.1021\/bi7023783.","journal-title":"Biochemistry"},{"key":"1036_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0022-1759(88)90240-2","volume":"109","author":"JR Gamble","year":"1988","unstructured":"Gamble JR, Vadas MA: A new assay for the measurement of the attachment of neutrophils and other cell types to endothelial cells. J Immunol Methods. 1988, 109: 175-184. 10.1016\/0022-1759(88)90240-2.","journal-title":"J Immunol Methods"},{"key":"1036_CR29","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.4161\/cbt.6.11.4833","volume":"6","author":"A Ratheesh","year":"2007","unstructured":"Ratheesh A, Ingle A, Gude RP: Pentoxifylline modulates cell surface integrin expression and integrin mediated adhesion of B16F10 cells to extracellular matrix components. Cancer Biol Ther. 2007, 6: 1743-1752. 10.4161\/cbt.6.11.4833.","journal-title":"Cancer Biol Ther"},{"key":"1036_CR30","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cellsig.2005.07.011","volume":"18","author":"T Kimura","year":"2006","unstructured":"Kimura T, Tomura H, Mogi C, Kuwabara A, Ishiwara M, Shibasawa K, Sato K, Ohwada S, Im DS, Kurose H: Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells. Cell Signal. 2006, 18: 841-850. 10.1016\/j.cellsig.2005.07.011.","journal-title":"Cell Signal"},{"key":"1036_CR31","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/00044067-200211000-00007","volume":"13","author":"DH Kang","year":"2002","unstructured":"Kang DH: Oxidative stress, DNA damage, and breast cancer. AACN Clin Issues. 2002, 13: 540-549. 10.1097\/00044067-200211000-00007.","journal-title":"AACN Clin Issues"},{"key":"1036_CR32","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.2307\/3432897","volume":"104","author":"DC Malins","year":"1996","unstructured":"Malins DC: Free radicals and breast cancer. Environ Health Perspect. 1996, 104: 1140-10.2307\/3432897.","journal-title":"Environ Health Perspect"},{"key":"1036_CR33","first-page":"535","volume":"44","author":"NODA Noriko","year":"2001","unstructured":"Noriko NODA, Hiro WAKASUGI: Cancer and Oxidative Stress. JMAJ. 2001, 44: 535-539.","journal-title":"JMAJ"},{"key":"1036_CR34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/oxfordjournals.bmb.a072628","volume":"49","author":"KZ Guyton","year":"1993","unstructured":"Guyton KZ, Kensler TW: Oxidative mechanism in carcinogenesis. Br Med Bull. 1993, 49: 523-544.","journal-title":"Br Med Bull"},{"key":"1036_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0891-5849(91)90074-D","volume":"10","author":"NF Boyd","year":"1991","unstructured":"Boyd NF, McGuire V: The possible role of lipid peroxidation in breast cancer risk. Free Radic Biol Med. 1991, 10: 185-190. 10.1016\/0891-5849(91)90074-D.","journal-title":"Free Radic Biol Med"},{"key":"1036_CR36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0304-3835(94)90008-6","volume":"82","author":"E K\u00f6ko\u011flu","year":"1994","unstructured":"K\u00f6ko\u011flu E, Karaarslan I, Karaarslan HM, Balo\u011flu H: Alterations of serum lipids and lipoproteins in breast cancer. Cancer Lett. 1994, 82: 175-178. 10.1016\/0304-3835(94)90008-6.","journal-title":"Cancer Lett"},{"key":"1036_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0009-9120(00)00200-9","volume":"34","author":"G Ray","year":"2001","unstructured":"Ray G, Husain SA: Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem. 2001, 34: 71-76. 10.1016\/S0009-9120(00)00200-9.","journal-title":"Clin Biochem"},{"key":"1036_CR38","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/jjco\/hyg059","volume":"33","author":"FA Abu-Bedair","year":"2003","unstructured":"Abu-Bedair FA, El-Gamal BA, Ibrahim NA, El-Aaser AA: Serum lipids and tissue DNA content in Egyptian female breast cancer patients. Jpn J Clin Oncol. 2003, 33: 278-82. 10.1093\/jjco\/hyg059.","journal-title":"Jpn J Clin Oncol"},{"key":"1036_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s005990070013","volume":"30","author":"AM Fiorenza","year":"2000","unstructured":"Fiorenza AM, Branchi A, Sommaviva D: Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res. 2000, 30: 141-145. 10.1007\/s005990070013.","journal-title":"Int J Clin Lab Res"},{"key":"1036_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.atherosclerosis.2003.07.003","volume":"171","author":"RS Rosenson","year":"2003","unstructured":"Rosenson RS: Antiatherothrombotic effects of nicotinic acid. Atherosclerosis. 2003, 171: 87-96. 10.1016\/j.atherosclerosis.2003.07.003.","journal-title":"Atherosclerosis"},{"key":"1036_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.atherosclerosis.2005.03.029","volume":"183","author":"CM Lee","year":"2005","unstructured":"Lee CM, Chien CT, Chang PY, Hsieh MY, Jui HY, Liau CS, Hsu SM, Lee YT: High-density lipoprotein antagonizes oxidized low-density lipoprotein by suppressing oxygen free-radical formation and preserving nitric oxide bioactivity. Atherosclerosis. 2005, 183: 251-258. 10.1016\/j.atherosclerosis.2005.03.029.","journal-title":"Atherosclerosis"},{"key":"1036_CR42","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/01.CIR.0000159351.95399.50","volume":"111","author":"SJ Nicholls","year":"2005","unstructured":"Nicholls SJ, Dusting GJ, Cutri B, Bao S, Drummond GR, Rye KA, Barter PJ: Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation. 2005, 111: 1543-1550. 10.1161\/01.CIR.0000159351.95399.50.","journal-title":"Circulation"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-10-65.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:50:14Z","timestamp":1630522214000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-10-65"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,30]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1036"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-10-65","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,30]]},"assertion":[{"value":"19 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"65"}}